Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression

BACKGROUND: To clarify the effects of cylcin E1 expression on HCC tumor progression, we studied the expression of cyclin E1 and inhibitory efficacy of regorafenib and sorafenib in HCC cells, and investigated a potential therapy that combines regorafenib treatment with cyclin E1 inhibition. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jianliang, Huang, Fei, Yao, Zhicheng, Jia, Changchang, Xiong, Zhiyong, Liang, Hao, Lin, Nan, Deng, Meihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660968/
https://www.ncbi.nlm.nih.gov/pubmed/31349793
http://dx.doi.org/10.1186/s12964-019-0398-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660968/
https://www.ncbi.nlm.nih.gov/pubmed/31349793
http://dx.doi.org/10.1186/s12964-019-0398-3

Ejemplares similares